Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring ...
Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, taking place in Barcelona from 11-14 March.
Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets reached new all-time ...
DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom ...
Management of gestational diabetes can be more efficient with the use continuous glucose monitoring (CGM), according to new research presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 ...
New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.
Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.
Tandem Diabetes Care, Inc. delivered strong Q4 '25 results, with revenue and gross margin beats driving a 32% stock surge. TNDM’s shift to a pay-as-you-go model will temporarily compress reported ...